Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Sleep and Chronic Post-Surgical Pain in Thoracic Surgery
NCT06849466Phase 4Enrolling by invitation
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in chronic postsurgical pain (CPSP) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Incidence of chronic post-surgical pain. Started Jul 2025; status: enrolling by invitation.
02
Drugs
dexmedetomidine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT06849466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06849466.